Professor Richard Scolyer BMedSci, MBBS, MD, FRCPA, FRCPath FAHMS is Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney; Co- Medical Director, Melanoma Institute Australia and Clinical Professor, The University of Sydney. He provides a clinical consultation service for the diagnosis of difficult pigmented lesions and receives more 2000 cases for opinion from Australasia and beyond annually. Richard effectively integrates his clinical practice with leading an award winning translational melanoma research laboratory. His record includes co-authoring more than 700 publications/book-chapters including in prestigious journals such as New England Journal of Medicine, Lancet, Nature, Cell, Nature Genetics, Lancet Oncology, Journal of Clinical Oncology, Journal of the National Cancer Institute and Cancer Discovery with >37,800 citations. His publications have received most highly cited awards on 5 other occasions. Recently, Richard was recognised as a Clarivate Web of Science “Highly Cited Researcher 2019”. According to Thomson Reuters ISI Web of Knowledge, Richard is the highest ever published scientist in the world in the field of melanoma pathology and he also has the highest H index in this field. Richard has presented on >350 occasions at conferences throughout the world. Richard has been chief investigator on 3 consecutive 5 year NHMRC program grants and has received multiple personal Fellowships from NHMRC and CINSW.
Young Investigators Award International
Sentinel Node Congress
Received the Young Investigators Award International at the Sentinel Node COngress in Yokohama, Japan in 2002.
The Pathologist’s 2020 Power List within the “Big Breakthroughs” category
The Pathologist Journal
The Pathologist’s 2020 Power List within the “Big Breakthroughts” category, which celebrates trailblazers working at the cutting edge and driving forward the future of the field. Link: https://thepathologist.com/power-list/2020
2020 Alumni Award for International Achievement
The University of Sydney
Highly Cited Researcher 2019
Clarivate Web of Science Group
Clarivate Web of Science Group “Highly Cited Researcher 2019” in recognition of exceptional research performance demonstrated by production of multiple highly cited papers that rank in the top 1% for field and year in Cross-Field. Issued 19 November 2019
Elson B. Helwig Memorial Lecture award
The American Society of Dermatopathology
The American Society of Dermatopathology presented RA Scolyer for his Elson B. Helwig Memorial Lecture an award in “recognition of excellence in the realm of diagnostic dermatopathology and for significant contribution to the dermatopathology literature and the education of fellows and colleagues”. Awarded at the ASDP 56th Annual Meeting in San Diego, California on 18 October 2019
Trailblazers” Power List
The Pathologist’s 2019
The Pathologist’s 2019 “Trailblazers” Power List – a power list of top 100 Pathologists worldwide with RS listed in top 10 and the only Australian in the top 100
Expertscape World Expert in Melanoma (top 0.1%)
ExpertScape DailyExperts
ExpertScape DailyExperts – 29/5/2019: Richard Scolyer recognised as an Expertscape World Expert in Melanoma (top 0.1%).
NSW Premier's ‘Professor Rob Sutherland AO Make a Difference Award”
New South Wales Premier's Office, Australian Government
2018 NSW Premier's ‘Professor Rob Sutherland AO Make a Difference Award” awarded to RA Scolyer
2018 GSK Award for Research Excellence
Research Australia
Research Australia’s 2018 GSK Award for Research Excellence Co-Awarded Professor Richard Scolyer and Professor Georgina Long
2018 Joanne Vandenberge Hill Award for Lifetime Achievement in Anatomical Pathology
MD Anderson Cancer Centre
2018 William O. Russell Lectureship and Joanne Vandenberge Hill Award for Lifetime Achievement in Anatomical Pathology, MD Anderson Cancer Centre
Outstanding Cancer Research: Wildfire Award for most highly cited paper in a peer reviewed journal
New South Wales Premier's Awards, Australian Government
2017 NSW Premier’s Awards for Outstanding Cancer Research: Wildfire Award for most highly cited paper in a peer reviewed journal. Rizos H, Menzies AM, Pupo GM, Carlino MS, Fung C, Hyman J, Haydu LE, Mijatov B, Becker TM, Boyd SC, Howle J, Saw R, Thompson JF, Kefford RF, Scolyer RA, Long GV. BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact. Clin Cancer Res. 2014 Apr 1;20(7):1965-77
2017 Excellence in Translational Cancer Research
New South Wales Premier's Awards, Australian Government
2017 Excellence in Translational Cancer Research, NSW Premier's Awards for Outstanding Cancer Research, Cancer Institute NSW. Scolyer RA and Long GV
2017 Top poster presentations
Sydney Catalyst International Cancer Research Symposium
2017 Sydney Catalyst International Cancer Research Symposium - Top poster presentations “CD103+ tumour-resident CD8+ T cells are associated with improved survival in immunotherapy naive melanoma patients and respond to anti-PD-1 immunotherapy”. Jarem Edwards, James S. Wilmott, Jason Madore, Tuba Nur Gide, Camelia Quek, Jinbiao Chen, Rehana Hewavisenti, Peter Hersey, Thomas Gebhardt, Wolfgang Weninger, Warwick J. Britton, Robyn P. M. Saw, John F. Thompson, Alexander M. Menzies, Georgina V. Lo
2017 Commendation Award (second prize) Pathologist/Scientist category for the best abstract
Australasian Division of the International Academy of Pathology
2017 Commendation Award (second prize) Pathologist/Scientist category for the best abstract at the Annual Scientific Meeting of the Australasian Division of the International Academy of Pathology. “Biomarkers of Response and Resistance to Combined Anti-CTLA-4 and Anti-PD-1 Immunotherapy in Melanoma Patients Utilising Multiplex Immunofluorescence” Nur Gide T, Quek C, Madore J, Menzies AM, Dent R, Carlino M, Guminski A, Saw R, Thompson J, Scolyer RA, Long GV, Wilmott J
Research Medal and Prize, 2016
Royal Prince Alfred Hospital Foundation
2016 Royal Prince Alfred Hospital Foundation Research Medal and Prize, 2016
Wildfire Award, most cited article published
2016 Cancer Institute NSW Premiers Awards
2016 Cancer Institute NSW Premiers Awards: Wildfire Award, most cited article published in 2013: Long GV, Wilmott JS, Capper D, Preusser M, Zhang YE, Thompson JF, Kefford RF, von Deimling A, Scolyer RA., Am J Surg Pathol 2013
2015 Winner Thomson Reuters Citation and Innovation Award
Thomson Reuters
2015 Winner Thomson Reuters Citation and Innovation Award for outstanding research team for research in BRAF-mutated melanoma. Co-winners Professor Georgina Long, Professor Richard Kefford, Professor Grant McArthur. 2015
2014 Premier’s Awards for Outstanding Cancer Research
New South Wales Premier Office, Australian Government
2014 Premier’s Awards for Outstanding Cancer Research: Wildfire Award for most cited article published in a peer reviewed journal between 1 January 2011– 31 December 2011; Long GV, Menzies AM, Nagrial AM, Haydu L, Hamilton AL, Mann GJ, Hughes TM, Thompson JF, Scolyer RA, Kefford, RF. “Prognostic and clinico-pathologic associations of oncogenic BRAF in metastatic melanoma.” J Clin Onc 2011
2013 NSW Premier’s Awards for Outstanding Cancer Research: Wildfire Award
New South Wales Premier's Office, Australian Government
2013 NSW Premier’s Awards for Outstanding Cancer Research: Wildfire Award for most highly cited paper in a peer reviewed journal between 1 January 2010– 31 December 2010: Guitera P, Pellacani G, Crotty KA, Scolyer RA, Li L-XL, Bassoli S, Vinceti M, Rabinovitz H, Longo C, Menzies SW. ‘The Impact of In Vivo Reflectance Confocal Microscopy on the Diagnostic Accuracy of Lentigo Maligna and Equivocal Pigmented and Nonpigmented Macules of the Face.’ J Invest Dermatol 2010
2012 Premier's Awards for Outstanding Cancer Research: Outstanding Cancer Research Fellow
New South Wales Premier's Office, Australian Government
2012 Premier's Awards for Outstanding Cancer Research: Outstanding Cancer Research Fellow,2012
2009 Premier's Award for Excellence in Translational Research
New South Wales Premier's Office, Australian Government
2009 Premier's Award for Excellence in Translational Research: Sydney Melanoma Unit (CINSW Translational Program Grant CIs: Mann, Thompson, Kefford, Scolyer, Hersey, Menzies, Christopherson), 2009
2009 Premier's Awards for Outstanding Cancer Research: Outstanding Cancer Research Fellow
New South Wales Premier's Office, Australian Government
2009 Premier's Awards for Outstanding Cancer Research: Outstanding Cancer Research Fellow, 2009
Commendation (2nd prize) for poster presentation (scientist/pathologist)
Annual Scientific Meeting of Australasian Division of the IAP, Sydney, 2005
Commendation (2nd prize) for poster presentation (scientist/pathologist): Zhuang L, Lee CS, Scolyer RA, McCarthy SW, Zhang X, Thompson JF, Bron LP, Hersey P. Involvement of Tumour Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) and Its Death Receptors (DR4 and DR5) in Human Melanoma. Annual Scientific Meeting of Australasian Division of the IAP, Sydney, 2005
1st prize for poster presentations
Swiss Society of Gynaecologists and Obstetricians
1st prize for poster presentations at Annual Meeting of the Swiss Society of Gynaecologists and Obstetricians, Lugano, Switzerland. Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, Scurry J, Scolyer RA, Fink D, Sutherland RL, Hacker NF, O’Brien PM. Galectin 4 and Meprin A are new candidate diagnostic markers for mucinous ovarian cancer, 2005
2nd Prize for Poster presentations at Annual Scientific Meeting
Australasian Division of the International Academy of Pathology
2nd Prize for Poster presentations at Annual Scientific Meeting of the Australasian Division of the International Academy of Pathology. Heinzelmann-Schwarz V, Gardiner-Garden M, Henshall S, Gish K, Scurry J, Scolyer R, Hacker N, O’Brien P, Sutherland R. Interstudy validation of gene expression profiles identifies candidate biomarkers of epithelial ovarian cancer, 2003
Young Investigators Award International
Sentinel Node Congress 2002
Young Investigators Award International. Sentinel Node Congress, Yokohama Japan,2002